Loading...
A Genetic Model of Substrate Reduction Therapy for Mucopolysaccharidosis
Inherited defects in the ability to catabolize glycosaminoglycans result in lysosomal storage disorders known as mucopolysaccharidoses (MPS), causing severe pathology, particularly in the brain. Enzyme replacement therapy has been used to treat mucopolysaccharidoses; however, neuropathology has rema...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Biochemistry and Molecular Biology
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3476295/ https://ncbi.nlm.nih.gov/pubmed/22952226 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.M112.403360 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|